Literature DB >> 20846529

An update to "The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe".

Mark Jit, Marie-Josée J Mangen, Hugues Melliez, Yazdan Yazdanpanah, Joke Bilcke, Heini Salo, W John Edmunds, Philippe Beutels.   

Abstract

A cost-effectiveness analysis of rotavirus vaccination in Belgium, England and Wales, Finland, France and the Netherlands published in 2009 was updated based on recent studies on rotavirus burden of disease and vaccine efficacy. All the qualitative conclusions in the previous study were found to remain valid. Vaccination remains cost-effective in Finland only when using plausible tender prices.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20846529     DOI： 10.1016/j.vaccine.2010.08.060

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  11 in total

Review 1.  Vaccination recommendations for Germany.

Authors:  Miriam Wiese-Posselt; Christine Tertilt; Fred Zepp
Journal:  Dtsch Arztebl Int       Date:  2011-11-04       Impact factor: 5.594

Review 2.  Systematic review of the economic value of diarrheal vaccines.

Authors:  Richard Rheingans; Mirna Amaya; John D Anderson; Poulomy Chakraborty; Jacob Atem
Journal:  Hum Vaccin Immunother       Date:  2014-05-27       Impact factor: 3.452

Review 3.  A critical literature review of health economic evaluations of rotavirus vaccination.

Authors:  Samuel Aballéa; Aurélie Millier; Sibilia Quilici; Stuart Caroll; Stavros Petrou; Mondher Toumi
Journal:  Hum Vaccin Immunother       Date:  2013-04-09       Impact factor: 3.452

4.  Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination.

Authors:  Patricia Bruijning-Verhagen; Marie-Josée J Mangen; Mariet Felderhof; Nico G Hartwig; Marlies van Houten; Léon Winkel; Wouter J de Waal; Marc J M Bonten
Journal:  BMC Med       Date:  2013-04-26       Impact factor: 8.775

Review 5.  Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world.

Authors:  Maarten J Postma; Mark Jit; Mark H Rozenbaum; Baudouin Standaert; Hong-Anh Tu; Raymond C W Hutubessy
Journal:  BMC Med       Date:  2011-07-08       Impact factor: 8.775

Review 6.  Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: a scoping review.

Authors:  Isla Ogilvie; Hanane Khoury; Mireille M Goetghebeur; Antoine C El Khoury; Carlo Giaquinto
Journal:  BMC Infect Dis       Date:  2012-03-19       Impact factor: 3.090

7.  Recommendation of rotavirus vaccination and herd effect: a budget impact analysis based on German health insurance data.

Authors:  Alexander Karmann; Andrea Jurack; Daniel Lukas
Journal:  Eur J Health Econ       Date:  2014-08-19

8.  Public health impact of accelerated immunization against rotavirus infection among children aged less than 6 months in the United States.

Authors:  Derek Weycker; Mark Andrew Atwood; Baudouin Standaert; Girishanthy Krishnarajah
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

9.  Will vaccination against rotavirus infection with RIX4414 be cost-saving in Germany?

Authors:  Stefanie Knoll; Christoph Mair; Ursula Benter; Katja Vouk; Baudouin Standaert
Journal:  Health Econ Rev       Date:  2013-11-18

10.  Selection and Interpretation of Scientific Evidence in Preparation for Policy Decisions: A Case Study Regarding Introduction of Rotavirus Vaccine Into National Immunization Programs in Sweden, Norway, Finland, and Denmark.

Authors:  Gry St-Martin; Ann Lindstrand; Synne Sandbu; Thea Kølsen Fischer
Journal:  Front Public Health       Date:  2018-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.